Literature DB >> 3631861

Results of treatment of recurrent dorsoradial wrist neuromas.

S E Mackinnon, A L Dellon.   

Abstract

Dorsoradial wrist neuromas diagnosed and treated by traditional techniques remain the most difficult for which to achieve satisfactory pain relief. Between 1981 and 1985, 52 patients with dorsoradial wrist neuromas were treated by neuroma resection and implantation of the nerves innervating the neuroma into the brachioradialis muscle. Critical to this treatment schema was preoperative use of nerve blocks to diagnose overlapping patterns of the cutaneous nerves in this region. Of patients for whom this technique was the first surgical treatment of their neuroma (primary group), 100% achieved good to excellent pain relief. Among patients in whom the neuroma had been operated on once previously (first recurrence group), 88% achieved good to excellent pain relief with the technique described in this article. Of patients treated who had had 3 or more previous "neuroma" operations (multiple recurrence group), this technique resulted in excellent pain relief in 56%. Factors contributing to a poorer result in the multiple recurrence group included duration of pain longer than 24 months and the patient's unemployment. The diagnostic and surgical approach detailed in this article has yielded clinical results that recommend this approach not only as the primary treatment of choice but also as the treatment to help patients with pain from recurrent dorsoradial neuromas. The apparent susceptibility of the superficial branch of the radial nerve (SBRN) to form painful neuromas has been well documented. Once established, the neuroma appears particularly resistant to treatment. Based on experimental and cadaveric studies, we have formulated a treatment plan for patients with dorsoradial wrist neuromas.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3631861     DOI: 10.1097/00000637-198707000-00009

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  9 in total

1.  Management of chronic facial pain.

Authors:  Christopher G Williams; A Lee Dellon; Gedge D Rosson
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2009-05

Review 2.  Morton's neuroma - Current concepts review.

Authors:  Maneesh Bhatia; Lauren Thomson
Journal:  J Clin Orthop Trauma       Date:  2020-04-10

3.  Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata.

Authors:  Simon Zimmermann; Richard M Fakin; Thomas Giesen; Pietro Giovanoli; Maurizio Calcagni
Journal:  J Vis Exp       Date:  2017-11-23       Impact factor: 1.355

4.  Neuropathic pain in patients with upper-extremity nerve injury.

Authors:  Christine B Novak; Joel Katz
Journal:  Physiother Can       Date:  2010-07-23       Impact factor: 1.037

5.  Painful pediatric traumatic neuroma: surgical management and clinical outcomes.

Authors:  Steven A Hanna; Joseph Catapano; Gregory H Borschel
Journal:  Childs Nerv Syst       Date:  2016-05-14       Impact factor: 1.475

Review 6.  Surgical interventions for the treatment of painful neuroma: a comparative meta-analysis.

Authors:  Louis H Poppler; Rajiv P Parikh; Miles J Bichanich; Kelsey Rebehn; Carrie R Bettlach; Susan E Mackinnon; Amy M Moore
Journal:  Pain       Date:  2018-02       Impact factor: 7.926

7.  CRPS of the upper or lower extremity: surgical treatment outcomes.

Authors:  A Lee Dellon; Eugenia Andonian; Gedge D Rosson
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2009-02-20

8.  Outcome of Stromal Vascular Fraction-Enriched Fat Grafting Compared to Intramuscular Transposition in Painful End-Neuromas of Superficial Radial Nerve: Preliminary Results.

Authors:  Simon Zimmermann; Richard M Fakin; Pietro Giovanoli; Maurizio Calcagni
Journal:  Front Surg       Date:  2018-02-16

9.  Predictive value of a diagnostic block in focal nerve injury with neuropathic pain when surgery is considered.

Authors:  Martijn J A Malessy; Ralph de Boer; Ildefonso Muñoz Romero; Job L A Eekhof; Erik W van Zwet; Michel Kliot; Albert Dahan; Willem Pondaag
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.